RFK Jr. eases access to unproven peptides despite opposition from FDA scientists
The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Colorectal cancer in younger patients shows distinct cellular and gene-activity patterns
United Kingdom
-
Business as a liberal art? Some high schools say yes
United States
-
Tariffs, diesel and computer chips are driving up costs for automakers
United States
-
Smartphones, ancient tracking skills and a future for desert lions
United Kingdom
-
Good News in History, October 29
United Kingdom
-
Immune changes linked to diabetes could guide development of new cancer treatments
United Kingdom
-
ATCC selected by ARPA-H to support next-generation BioStabilization technologies
United Kingdom
-
Your blood pressure could be dangerous even when your numbers look normal
United States